(Q37301305)

19 August 2017

1 reference

title

Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus (English)

1 reference

19 August 2017

1 reference

1 reference

molecular interaction

1 reference

Barbara Roe

1

1 reference

19 August 2017

William W Hall

series ordinal

2

1 reference

19 August 2017

publication date

20 October 2008

1 reference

Expert Reviews in Molecular Medicine

19 August 2017

published in

1 reference

19 August 2017

volume

10

1 reference

19 August 2017

page(s)

e30

1 reference

Apoptosis: a mechanism of acute and chronic liver injury

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Intra-hepatic messenger RNA levels for interferons and related genes in hepatitis C virus/HIV co-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus infection in the asymptomatic British blood donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Pathophysiology of hepatitis C virus infection and related liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The C-X-C chemokine IP-10 stimulates HIV-1 replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Rules of chemokine receptor association with T cell polarization in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Options for treatment of hepatitis C in HIV-infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4(+) and CD8(+) T-cell responses to hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor mediated liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Determinants of viral clearance and persistence during acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

CD8 Epitope Escape and Reversion in Acute HCV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Relation between HIV-1 and hepatitis C viral load in patients with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Survival in patients with HIV infection and viral hepatitis B or C: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C and progression of HIV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The trans-activator gene of HTLV-III is essential for virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The packaging and maturation of the HIV-1 Pol proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Regulating the functions of the HIV-1 matrix protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

HIV-1: fifteen proteins and an RNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Molecular virology of hepatitis C virus (HCV): 2006 update

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Unravelling hepatitis C virus replication from genome to function

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

A second hepatitis C virus-encoded proteinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C and Human Immunodeficiency Virus Envelope Proteins Cooperatively Induce Hepatocytic Apoptosis via an Innocent Bystander Mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus particle detected by immunoelectron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C in the HIV-Infected Person

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

HIV and hepatitis C co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The apoptosome: signalling platform of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

Cell suicide and caspases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS1462399408000847

21 January 2018

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

HCV-HIV coinfection: simple messages from a complex disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Cellular and molecular mechanisms of liver injury

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Detection of elevated caspase activation and early apoptosis in liver diseases

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Overview of cell death signaling pathways

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Downregulation of cell surface CD4 by nef

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Biosynthesis and biochemical properties of the hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Prevalence of antibodies against hepatitis C virus in the adult German population.

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Internal ribosome entry site within hepatitis C virus RNA

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1017%2FS1462399408000847

7 January 2021

10.1017/S1462399408000847

Identifiers

DOI

1 reference

19 August 2017

1 reference